Friday, March 19, 2010: 2:00 PM-3:30 PM
Centennial I-II (Hyatt Regency Atlanta)
CME Credits: 1.50
Summary: While other developed countries are able to assess antimicrobial use, data have not been generally available in the US. Additionally, the best metrics for measuring antimicrobial use remain controversial. This session will explore the approaches to obtaining use data in the EU, as well as the potential for using this information to guide appropriate utilization.Learning Objectives:
- Discuss the economics and implications of approaching antibiotics as a limited national resource in an effort to guide appropriate use.
- Describe the successes and challenges of using point prevalence studies to obtain antimicrobial use data from hospitals throughout the European Union (EU).
- Explore the efficacy of benchmarking antimicrobial use as a means of improving utilization in healthcare settings.
Society of Infectious Diseases Pharmacists (SIDP)
David Schwartz, MD and Melinda Nehauser, PharmD